Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Lymphopenia | 20% - 72% | 7% - 53% | x | x |
| Leukopenia | 3% - 35% | 1% - 10% | x | x |
| Nausea | 2% - 36% | 2% - 35% | x | x |
| Diarrhoea | 2% - 25% | 2% - 15% | x | x |
| Vomiting | 2% - 19% | 2% - 14% | x | x |
| Neutropenia | 2% - 18% | 1% - 5% | x | x |
| Oedema peripheral | 2% - 13% | 1% - 10% | x | |
| Anaemia | 2% - 93% | 6% - 88% | x | |
| Thrombocytopenia | 2% - 31% | 1% - 22% | x | x |
| Renal failure | 1% - 3% | 1% | x | |
| Pancytopenia | 1% - 2% | 0% | x | x |
| Neoplasm malignant | x | x | ||
| Dehydration | x | |||
| Oedema | x | |||
| Gastrointestinal disorder | x | x | ||
| Leukaemia | x | |||
| Myelodysplastic syndrome | x | |||
| Osteosarcoma | x | |||
| Pain | x | x | ||
| Swelling | x | |||
| Erythema | x | x | ||
| Urinary tract disorder | x | |||
| Injection site reaction | x | x | ||
| Bone cancer metastatic | x | |||
| Hypovolaemia | x | |||
| Blood and lymphatic system disorders | x | x | ||
| Metastatic neoplasm | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |